Yüklüyor......
Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund
BACKGROUND: The NHS Cancer Drugs Fund (CDF) was established in 2010 to reduce delays and improve access to cancer drugs, including those that had been previously appraised but not approved by NICE (National Institute for Health and Care Excellence). After 1.3 billion GBP expenditure, a UK parliament...
Kaydedildi:
| Yayımlandı: | Ann Oncol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834015/ https://ncbi.nlm.nih.gov/pubmed/28453615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx110 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|